Z Urology Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2013
NCT02398370
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Melissa Marchand

Active Ingredients

Drugs in Phase 1 Trials (1)

placental matrix-derived mesenchymal stem cells (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erectile Dysfunction (Phase 1)

Penile Induration (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1